E
Eric Lerebours
Researcher at French Institute of Health and Medical Research
Publications - 220
Citations - 8942
Eric Lerebours is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Inflammatory bowel disease & Crohn's disease. The author has an hindex of 50, co-authored 220 publications receiving 8446 citations.
Papers
More filters
Journal ArticleDOI
Natural History of Pediatric Crohn's Disease: A Population-Based Cohort Study
Gwenola Vernier–Massouille,Mamadou Balde,Julia Salleron,Dominique Turck,Jean Louis Dupas,Olivier Mouterde,Véronique Merle,Jean Louis Salomez,Julien Branche,Marti R,Eric Lerebours,Antoine Cortot,Corinne Gower–Rousseau,Jean-Frederic Colombel +13 more
TL;DR: Pediatric Crohn's disease was characterized by frequent occurrence, with time, of a severe phenotype with extensive, complicated disease and immunosuppressive therapy may improve the natural history of this disease and decrease the need for performing surgery.
Journal ArticleDOI
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial
P. Marteau,Marc Lémann,P. Seksik,D. Laharie,J.-F. Colombel,Yoram Bouhnik,Guillaume Cadiot,Soulé Jc,Arnaud Bourreille,Etienne Henry Metman,Eric Lerebours,F. Carbonnel,J.L. Dupas,Michel Veyrac,Benoit Coffin,J. Moreau,V. Abitbol,S. Blum-Sperisen,Jean-Yves Mary +18 more
TL;DR: The probiotic strain L johnsonii LA1 (4×109 cfu/day) did not have a sufficient effect, if any, to prevent endoscopic recurrence of Crohn’s disease.
Journal ArticleDOI
A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine.
Marc Lémann,Jean-Yves Mary,Jean-Frederic Colombel,Bernard Duclos,Soulé Jc,Eric Lerebours,Robert Modigliani,Yoram Bouhnik +7 more
TL;DR: This study shows that azathioprine withdrawal is not equivalent to continued therapy with azathyprine for maintenance of remission in patients with Crohn's disease who have been in remission on azithioprine for > or = 3.5 years.
Journal ArticleDOI
Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study
Cloé Charpentier,Julia Salleron,Guillaume Savoye,Mathurin Fumery,Véronique Merle,Jean-Eric Laberenne,Francis Vasseur,Jean-Louis Dupas,Antoine Cortot,Luc Dauchet,Laurent Peyrin-Biroulet,Eric Lerebours,Jean-Frederic Colombel,Jean-Frederic Colombel,Corinne Gower-Rousseau +14 more
TL;DR: Clinical course is mild in elderly-onset IBD patients and this information would need to be taken into account by physicians when therapeutic strategies are established.
Journal ArticleDOI
The Natural History of Pediatric Ulcerative Colitis: A Population-Based Cohort Study
Corinne Gower-Rousseau,Luc Dauchet,Gwenola Vernier-Massouille,Emmanuelle Tilloy,Franck Brazier,Véronique Merle,Jean-Louis Dupas,Guillaume Savoye,Mamadou Balde,Marti R,Eric Lerebours,Antoine Cortot,J L Salomez,Dominique Turck,Jean-Frederic Colombel +14 more
TL;DR: Pediatric UC was characterized by widespread localization at diagnosis and a high rate of disease extension, which was influenced by disease extension and was associated with the presence of EIMS at diagnosis.